glp-1 drug news today A wave of new #GLP1 options for type 2 #Diabetes and #Obesity was a major focus at #ADA2026. In the latest JAMA Medical podcast, Jennifer Abbasi interviews Rita Kalyani, MD GLP-1 Medications – FDA Guidance

metformin Jardiance and metformin can both support modest weight loss, but between the two, metformin will likely be more effective (and more affordable)

Scand J Gastroenterol

What this adds up to clinically: GLP-1s are best understood as treating the underlying metabolic disease, not just as a weight loss intervention

doi: 10.3389/FPHAR.2022.825417 73 HlscherC

Consequently, once-daily subcutaneous administration of liraglutide 3.0 mg was developed for the treatment of obesity [21] and once-weekly subcutaneous administration of semaglutide 2.4 mg is currently being investigated in phase III trials for this indication [22]

Through the Agricultural Experiment Station and the Cooperative Extension Service, the Division of Agriculture conducts research and extension work within the nations historic land grant education system